Healthcare Today Michigan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Michigan.

Press releases published on May 28, 2026

Your Body is Not a Trend: Leading Plastic Surgeons Expose Ethical Crisis and Safety Risks of Social Media Beauty Boom
MEDIROM Group Reports Q1 2026 Results
New Research from ATI Advisory Finds I-SNP Enrollment Associated with Better Outcomes for Long-Term Care Residents
Fortis Life Sciences erweitert sein AbNano®-Portfolio um die erste VHH-Bibliothek, die aus peripheren natürlichen Killerzellen gewonnen wurde und der schnellen Antikörperentwicklung dient
Fortis Life Sciences enrichit son portefeuille AbNano® avec la première bibliothèque VHH dérivée de cellules tueuses naturelles périphériques pour accélérer la découverte d’anticorps
Taurus Meds TRT Claims Evaluated: Powerful Testosterone Replacement Therapy & Taurus Charge ED Medication
Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference
Wegweisende Therapie bei fortgeschrittener Herzinsuffizienz: Ergebnisse der klinischen Studie BIOVAT-HF im NEJM veröffentlicht
Keeps TRT Claims Evaluated: Clinician-Prescribed Testosterone Replacement Therapy Medication Online
Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira’s Director Nominees
CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter
LB Pharmaceuticals to Participate in Upcoming June Investor Events
CG Oncology to Present at Upcoming Investor Conferences in June
Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference
HealthEquity Reports First Quarter Ended April 30, 2026 Financial Results; Raises Guidance
Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy
Outlook Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Today Michigan

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.